PhenAID Platform
Identify Better Drug Candidates
with Morphological Profiling
PhenAID platform streamlines the identification and profiling of small molecule drug candidates, leveraging the power of multimodal data. By combining molecular structures, High Content Screening images, and multi-omics data, it significantly elevates the drug discovery process. The platform enables the performance of a variety of predictive and generative tasks through easy-to-configure AI-based pipelines.
Watch a short video about PhenAID platform WATCH the DEMO
JUMP-CP SUPPORTING PARTNER
Check our tool to explore JUMP-CP data. JUMP-CP Data Explorer
Ardigen phenAID Platform Capabilities
Combine Varied Data Types Through Artificial Intelligence
Ardigen phenAID Platform at Any Stage of Your Research:
Our solution will improve your drug design process through seamless AI-lab integration. The AI platform is a comprehensive solution that fits into your drug discovery process and can be used out-of-the-box in every step of the process. We can increase your chances of obtaining a drug candidate that will successfully pass the clinical trials. Whether you are just starting your project and looking for compounds to screen, or if you have already gathered phenotypic screening outcomes, we can help.
With our platform you are able to:
- find the targets and off-targets of your molecules;
- narrow the chemical search space;
- optimize your compounds to obtain the desired phenotype;
- assign Mode of Action to chemical compounds.
